Cargando…
A new mode of ventilation for interventional pulmonology. A case with EBUS-TBNA and debulking
Lung cancer is still underdiagnosed mainly due to lack of symptoms. Most patients are diagnosed in a late stage where unfortunately only systematic therapy can be applied. Fortunately in the last five years several novel therapies and combinations have emerged. However; in certain situations local t...
Autores principales: | Zarogoulidis, Paul, Huang, Haidong, Bai, Chong, Kosmidis, Christoforos, Porpodis, Konstantinos, Kallianos, Anastasios, Veletza, Lemonia, Trakada, Georgia, Benhassen, Naim, Hohenforst-Schmidt, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723371/ https://www.ncbi.nlm.nih.gov/pubmed/29234593 http://dx.doi.org/10.1016/j.rmcr.2017.11.006 |
Ejemplares similares
-
Progressive dyspnea due to pulmonary carcinoid tumorlets
por: Kallianos, Anastasios, et al.
Publicado: (2017) -
Cryo-Biopsy versus 19G needle versus 22G needle with EBUS-TBNA endoscopy
por: Oikonomidou, Rena, et al.
Publicado: (2022) -
Immunotherapy “Shock” with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma
por: Zarogoulidis, Paul, et al.
Publicado: (2017) -
Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases
por: Zarogoulidis, Paul, et al.
Publicado: (2017) -
Immunotherapy “Shock” a case series of PD-L1 100% and pembrolizumab first-line treatment
por: Zarogoulidis, Paul, et al.
Publicado: (2017)